The Biopharma Pod podcast

Immunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech

0:00
5:10
Spola tillbaka 15 sekunder
Spola framåt 15 sekunder
Immunocore is looking for more licensees for its cancer targeting technology following recent discovery and development deals with GSK and Genentech.

Fler avsnitt från "The Biopharma Pod"